TY - CPAPER AU - Bermel,R AU - Comi,G AU - Eralinna,J-P AU - Leist,TP AU - Nicholas,R AU - Oreja-Guevara,C AU - Siva,A AU - Van,Wijmeersch B AU - Wiendl,H AU - Bernasconi,C AU - Buffels,R AU - Csoboth,C AU - Han,J AU - Musch,B AU - Vermersch,P EP - 616 PB - SAGE PUBLICATIONS LTD PY - 2016/// SN - 1352-4585 SP - 615 TI - Design of two phase III open-label trials evaluating ocrelizumab in patients with relapsing-remitting multiple sclerosis and suboptimal response to disease-modifying treatment UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000383267202379&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=a2bf6146997ec60c407a63945d4e92bb ER -